ATP binding cassette transporters and cancer: revisiting their controversial role

Parul Sharma1, Navneet Singh2, Siddharth Sharma1

  • 1Department of Biotechnology, Thapar Institute of Engineering & Technology, Patiala, India.

Pharmacogenomics
|November 16, 2021
PubMed

Insights

ATP-binding cassette (ABC) transporters are crucial in drug resistance and chemotherapy. Modulating these transporters offers a promising strategy to overcome multidrug resistance in cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • ATP-binding cassette (ABC) transporters are membrane proteins involved in efflux of compounds.
  • ABC transporters are expressed in various human tissues, including lung, liver, kidney, brain, and intestine.
  • These transporters play a critical role in the development of multidrug resistance (MDR), a major challenge in cancer chemotherapy.

Purpose of the Study:

  • To review the role of ABC transporters in multidrug resistance.
  • To explore strategies for overcoming ABC transporter-mediated drug resistance.
  • To discuss the potential clinical applications of modulating ABC transporters in oncology.

Main Methods:

  • Literature review of preclinical and clinical studies on ABC transporters and multidrug resistance.
  • Analysis of the mechanisms by which ABC transporters contribute to drug efflux and resistance.
  • Evaluation of therapeutic strategies targeting ABC transporters.

Main Results:

  • ABC transporters facilitate the efflux of various compounds, reducing intracellular drug concentrations.
  • Overexpression of ABC transporters is a key mechanism underlying multidrug resistance in cancer.
  • Modulators of ABC transporters are being investigated to enhance chemotherapy efficacy.

Conclusions:

  • Targeting ABC transporters is a viable strategy to overcome multidrug resistance.
  • Further research and clinical trials are needed to translate these findings into effective cancer treatments.
  • Modulation of ABC transporters holds promise for improving patient outcomes in oncology.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
5.3K
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
3.0K
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
1.3K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
610
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K